News

New NPDUIS analytical report: New Drug Pipeline Monitor, sixth edition

January 13, 2015

The PMPRB released the sixth edition of the New Drug Pipeline Monitor on December 31, 2014.

This report identifies 27 drugs under development (pipeline drugs) that may have an impact on drug plan expenditures in Canada. The pipeline list includes drugs in Phase III (late-stage) clinical trials or under review by the United States Food and Drug Administration as drugs at this stage are more likely to proceed in the near future to regulatory approval and marketing in Canada.

Back to Listing